High Content Phenotypic Screening and Analysis Enhances Drug Discovery

Molly Shoichet and Bridget Wagner discuss strategies for using phenotypic screening to identify novel agents against diseases such as cancer and diabetes.

The Scientist Creative Services Team
Oct 7, 2020

FREE Webinar

Wednesday, November 18, 2020
2:30 - 4:00 PM, Eastern Standard Time

Register Now

Phenotypic screening identifies potential drug candidates based on their ability to modulate cells or organisms in a desired manner. However, phenotypic screening depends on models that can both induce pathological behavior and facilitate high throughput/high content screening. In this webinar from The Scientist, Molly Shoichet and Bridget Wagner will discuss strategies for creating such models and outline how they use them to identify agents to counter chronic diseases, such as cancer and diabetes.

Topics to be covered

  • How 3D cell culture enables predictive drug screening
  • Phenotypic screening for small molecule discovery in the beta cell

Register Now

Meet the Speakers:

Molly Shoichet, PhD, FRS, OC
Professor, Chemical Engineering & Applied Chemistry
Biomaterials & Biomedical Engineering
University of Toronto
Tier 1 Canada Research Chair in Tissue Engineering

Bridget Wagner, PhD
Director of Pancreatic Cell Biology and Metabolic Disease
Institute Scientist
Broad Institute of MIT and Harvard